216 related articles for article (PubMed ID: 10199542)
1. Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin.
Giebler R; Schmidt U; Koch S; Peters J; Scherer R
Crit Care Med; 1999 Mar; 27(3):597-604. PubMed ID: 10199542
[TBL] [Abstract][Full Text] [Related]
2. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
3. The influence of C1-esterase inhibitor substitution on coagulation and cardiorespiratory parameters in an endotoxin-induced rabbit model of hypercoagulability.
Scherer RU; Giebler RM; Schmidt U; Paar D; Kox WJ
Semin Thromb Hemost; 1996; 22(4):357-66. PubMed ID: 8944422
[TBL] [Abstract][Full Text] [Related]
4. Effects of N omega-nitro-L-arginine methyl ester on the endotoxin-induced disseminated intravascular coagulation in porcine septic shock.
Jourdain M; Tournoys A; Leroy X; Mangalaboyi J; Fourrier F; Goudemand J; Gosselin B; Vallet B; Chopin C
Crit Care Med; 1997 Mar; 25(3):452-9. PubMed ID: 9118662
[TBL] [Abstract][Full Text] [Related]
5. Effects of low molecular weight heparin, alone or combined with antithrombin III, on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbits.
Hermida J; Montes R; Muñoz MC; Orbe J; Páramo JA; Rocha E
Am J Hematol; 1999 Jan; 60(1):6-11. PubMed ID: 9883799
[TBL] [Abstract][Full Text] [Related]
6. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin-induced disseminated intravascular coagulation in rabbits: effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality.
Hermida J; Montes R; Páramo JA; Rocha E
J Lab Clin Med; 1998 Jan; 131(1):77-83. PubMed ID: 9452130
[TBL] [Abstract][Full Text] [Related]
8. Effect of heparin and/or antithrombin III on the generation of endotoxin-induced plasminogen activator inhibitor.
Gómez C; Páramo JA; Colucci M; Rocha E
Thromb Haemost; 1989 Sep; 62(2):694-8. PubMed ID: 2683190
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.
Hauptman JG; Hassouna HI; Bell TG; Penner JA; Emerson TE
Circ Shock; 1988 Jun; 25(2):111-22. PubMed ID: 3390893
[TBL] [Abstract][Full Text] [Related]
10. Effects of prostacyclin substitution on systemic procoagulant turnover and cardiorespiratory variables in experimental hypercoagulability.
Scherer R; Schmidt U; Kox W; Paar D
Haemostasis; 1997; 27(1):16-24. PubMed ID: 9097082
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor.
Guerrero R; Velasco F; Rodriguez M; Lopez A; Rojas R; Alvarez MA; Villalba R; Rubio V; Torres A; del Castillo D
J Clin Invest; 1993 Jun; 91(6):2754-60. PubMed ID: 8514883
[TBL] [Abstract][Full Text] [Related]
12. A purified antithrombin III--heparin complex as a potent inhibitor of thrombin in porcine endotoxin shock.
Spannagl M; Hoffmann H; Siebeck M; Weipert J; Schwarz HP; Schramm W
Thromb Res; 1991 Jan; 61(1):1-10. PubMed ID: 2020936
[TBL] [Abstract][Full Text] [Related]
13. The effect of fibrinolytic enzyme FIIa from Agkistrodon acutus venom on disseminated intravascular coagulation in rabbits.
Lin X; Liang XX; Chen JS; Chen Q; Qiu PX; Yan GM
Transl Res; 2007 Nov; 150(5):295-302. PubMed ID: 17964518
[TBL] [Abstract][Full Text] [Related]
14. Substitution of antithrombin III in shock and DIC: a randomized study.
Blauhut B; Kramar H; Vinazzer H; Bergmann H
Thromb Res; 1985 Jul; 39(1):81-9. PubMed ID: 4035650
[TBL] [Abstract][Full Text] [Related]
15. Treatment of septic shock in rats with nitric oxide synthase inhibitors and inhaled nitric oxide.
Pedoto A; Tassiopoulos AK; Oler A; McGraw DJ; Hoffmann SP; Camporesi EM; Hakim TS
Crit Care Med; 1998 Dec; 26(12):2021-8. PubMed ID: 9875915
[TBL] [Abstract][Full Text] [Related]
16. Treatment of septic shock with a protease inhibitor in a canine model: a prospective, randomized, controlled trial.
Tani T; Aoki H; Yoshioka T; Lin KJ; Kodama M
Crit Care Med; 1993 Jun; 21(6):925-30. PubMed ID: 8389269
[TBL] [Abstract][Full Text] [Related]
17. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
Taylor FB; Wada H; Kinasewitz G
Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
[TBL] [Abstract][Full Text] [Related]
18. Significane of intravascular coagulation in canine endotoxin shock.
From AH; Spink WW; Knight D; Gewurz H
Infect Immun; 1975 May; 11(5):1010-3. PubMed ID: 1091556
[TBL] [Abstract][Full Text] [Related]
19. Rapid in vivo induction of leukocyte tissue factor mRNA and protein synthesis following low dose endotoxin administration to rabbits.
Brutzki TC; Kulczycky MJ; Bardossy L; Clarke BJ; Blajchman MA
Hematol J; 2001; 2(3):188-95. PubMed ID: 11920244
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model.
Schiffer ER; Reber G; De Moerloose P; Morel DR
Crit Care Med; 2002 Dec; 30(12):2689-99. PubMed ID: 12483060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
